The impairment of Ikaros function, as a result of deletion and/or inactivating mutation of a single IKZF1 allele, is linked to the development of ALL that is characterized by a high rate of relapse and poor outcome. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.